Vantage Consulting Group Inc — 13F Holdings & Portfolio

CIK 1843547 · latest 13F-HR filed 2026-02-11

Vantage Consulting Group Inc manages $19.7M in 13F-reported U.S. long-equity assets across 3 reported positions as of its 2025-12-31 13F-HR filing. Its largest disclosed positions are BW (77.68%), ADCT (12.23%), CBUS (10.09%). Quarter over quarter (versus its 2025-09-30 filing) the fund opened 0 new positions, exited 0, added to 2, and trimmed 1.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM

$19.7M

Long-equity book

Holdings

3

Distinct positions

Period

2025-12-31

Filed 2026-02-11

Q/Q Activity

+0 / −0 / ↑2 / ↓1

vs 2025-09-30

Firm Profile & Key People
Name Title / Status Ownership Type

Top Adds (vs prior quarter)

  • Babcock & Wilcox Enterprises Inc.$8.3M +118.6%
  • Cibus, Inc.$514.8K +34.9%
Show all 2

Top Trims

  • ADC Therapeutics SA-$321.0K -11.7%
Show all 1

New Positions

  • No new positions this quarter.
Show all 0

Exited Positions

  • No exits this quarter.
Show all 0
All Holdings

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 Babcock & Wilcox Enterprises Inc. BW 05614L209 $15.3M 77.68% 2,416,200 SH
2 ADC Therapeutics SA ADCT H0036K147 $2.4M 12.23% 682,998 SH
3 Cibus, Inc. CBUS 17166A101 $2.0M 10.09% 1,143,949 SH
Filing History
Period Filed AUM Holdings Accession
2025-12-31 2026-02-11 $19.7M 3 0001843547-26-000002
2025-09-30 2025-11-06 $11.2M 3 0001843547-25-000016